Home · Stock · KVUE

KVUE Kenvue Inc

Which ETFs hold KVUE? Kenvue Inc is held by 2 funds tracked by ETFpeek.

Held by 2 funds todayData as of 31 Aug 2026
Consumer DefensiveHousehold & Personal Products
$17.73
+12.9% 1y
$14.0252-week range$20.13
Market cap
$33.0B
P/E
20.6
Dividend
4.74%
3-month
-6.9%
CEO
Mr. Kirk L. Perry
Revenue · last 4 qtrs (+3.0% YoY)

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Provider

Currently Held By

VANGUARD
VOO
Weight in fund0.05%
Shares held51,011,076
Market value$963.1M
View fund →
SMARTSHARES
USF
Smart US 500 ETF
via VOO
Weight in fund0.05%
Shares held—
Market value$687K NZD
View fund →
Not held by the selected provider.
last 90 days
Net flow (90d):+$1.3M (5 without value)·10 BUY / 7 SELL·score ≥ 40
DatePersonActionPlanSharesValueScore i
2 Oct 2026
Carlton Lawson
Group President of Europe, Middle East & Africa
BUYVested (RSU)36,597$629K40
2 Oct 2026
Meredith Stevens
Chief Operations Officer
BUYVested (RSU)35,754$615K40
Net flow (90d):+$1.3M (5 without value)·10 BUY / 7 SELL·showing all trades
DatePersonActionPlanSharesValueScore i
2 Oct 2026
Carlton Lawson
Group President of Europe, Middle East & Africa
BUYVested (RSU)36,597$629K40
2 Oct 2026
Meredith Stevens
Chief Operations Officer
BUYVested (RSU)35,754$615K40
2 Oct 2026
Matthew Orlando
General Counsel
SELLVested (RSU)14,749$254K30
2 Oct 2026
Matthew Orlando
General Counsel
BUYVested (RSU)35,754$615K30
2 Oct 2026
Meredith Stevens
Chief Operations Officer
SELLVested (RSU)15,192$261K30
2 Oct 2026
Caroline Tillett
Chief Scientific Officer
SELLVested (RSU)8,471$146K30
2 Oct 2026
Caroline Tillett
Chief Scientific Officer
BUYVested (RSU)24,732$425K30
2 Oct 2026
Heather Howlett
Interim CFO & Chief Accounting Officer
SELLVested (RSU)5,566$96K30
2 Oct 2026
Heather Howlett
Interim CFO & Chief Accounting Officer
BUYVested (RSU)10,881$187K30
1 Oct 2026
Michael Wondrasch
Chief Technology & Data Officer
BUYOption Exercise66,029—30
1 Oct 2026
Michael Wondrasch
Chief Technology & Data Officer
SELLVested (RSU)21,031$362K30
28 Sep 2026
Richard E Jr Allison
Director / Other
BUYVested (RSU)1,300—0
28 Sep 2026
Jeffrey C Smith
Director / Other
BUYVested (RSU)1,300—0
25 Sep 2026
Meredith Stevens
Chief Operations Officer
BUYOption Exercise1,461
2 tranches
—30
25 Sep 2026
Meredith Stevens
Chief Operations Officer
SELLVested (RSU)1,461
2 tranches
$26K0
Data: Finnhub (SEC Form 4 filings) · Score: ETFpeek heuristic
0 trades
DateFundDirectionShares Changed% Δ ETF i% Δ Position i
No trades recorded yet.
No trade history for SmartShares funds — their underlying ETFs are passive index trackers, so day-to-day rebalancing is minimal.

More stocks in these funds